Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,450.00p
   
  • Change Today:
    -175.00p
  • 52 Week High: 4,420.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 33,480
  • Market Cap: £128.01m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
23.39% below the market average23.39% below the market average23.39% below the market average23.39% below the market average23.39% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
1yr Revenue Growth
15.54% above the market average15.54% above the market average15.54% above the market average15.54% above the market average15.54% above the market average
17.24% below the sector average17.24% below the sector average17.24% below the sector average17.24% below the sector average17.24% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
63.36% above the market average63.36% above the market average63.36% above the market average63.36% above the market average63.36% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
40.11% below the market average40.11% below the market average40.11% below the market average40.11% below the market average40.11% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
38.08% above the market average38.08% above the market average38.08% above the market average38.08% above the market average38.08% above the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Price Book Ratio
92.51% below the market average92.51% below the market average92.51% below the market average92.51% below the market average92.51% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
71.22% below the market average71.22% below the market average71.22% below the market average71.22% below the market average71.22% below the market average
64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average
Price Chg 3m
64.99% below the market average64.99% below the market average64.99% below the market average64.99% below the market average64.99% below the market average
42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
63.93% below the market average63.93% below the market average63.93% below the market average63.93% below the market average63.93% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Momentum 20
98.82% below the market average98.82% below the market average98.82% below the market average98.82% below the market average98.82% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
73.11% above the market average73.11% above the market average73.11% above the market average73.11% above the market average73.11% above the market average
93.10% above the sector average93.10% above the sector average93.10% above the sector average93.10% above the sector average93.10% above the sector average
ROCE
77.55% above the market average77.55% above the market average77.55% above the market average77.55% above the market average77.55% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
90.50% above the market average90.50% above the market average90.50% above the market average90.50% above the market average90.50% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Forecast EPS
76.74% above the market average76.74% above the market average76.74% above the market average76.74% above the market average76.74% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.82% below the market average35.82% below the market average35.82% below the market average35.82% below the market average35.82% below the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average
Operating Profit Loss
26.28% above the market average26.28% above the market average26.28% above the market average26.28% above the market average26.28% above the market average
81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
23.86% below the market average23.86% below the market average23.86% below the market average23.86% below the market average23.86% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Cash
8.94% below the market average8.94% below the market average8.94% below the market average8.94% below the market average8.94% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
75.34% below the market average75.34% below the market average75.34% below the market average75.34% below the market average75.34% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,450.00p
Change Today -175.00p
% Change -6.67 %
52 Week High 4,420.00
52 Week Low 2,350.00
Volume 33,480
Shares Issued 5.22m
Market Cap £128.01m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.77% above the market average7.77% above the market average7.77% above the market average7.77% above the market average7.77% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Price Trend
70.31% below the market average70.31% below the market average70.31% below the market average70.31% below the market average70.31% below the market average
51.11% below the sector average51.11% below the sector average51.11% below the sector average51.11% below the sector average51.11% below the sector average
Income
58.06% above the market average58.06% above the market average58.06% above the market average58.06% above the market average58.06% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
6.38% below the market average6.38% below the market average6.38% below the market average6.38% below the market average6.38% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 05-Aug-2025

Time Volume / Share Price
14:10 13,388 @ 2,420.00p
16:35 50 @ 2,450.00p
16:35 50 @ 2,450.00p
16:27 11 @ 2,514.00p
16:21 3 @ 2,514.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page